What Is Synthetic Biology? Engineering Life From Scratch
An accessible introduction to synthetic biology — the field that applies engineering principles to living systems, with applications ranging from biofuels to programmable medicines.
Synthetic biology applies engineering principles to biological systems, enabling scientists to design, build, and program living organisms with predictable behavior. From Craig Venter's creation of the first synthetic cell to Ginkgo Bioworks' cell programming platform, the field encompasses gene circuit design, metabolic engineering, directed evolution, and xenobiology. Synthetic biology applications span biofuels, lab-grown meat, living medicines, biosensors, and novel materials, making it one of the most commercially impactful branches of biotechnology.
Engineered networks of genes that perform logical functions inside cells
Reprogramming cellular metabolism to produce valuable chemicals and materials
Laboratory evolution of proteins toward desired functions through iterative mutation and selection
Protecting against misuse of synthetic biology tools and engineered organisms
Automated facilities using robotics and AI to design, build, and test biological systems
Defining the smallest set of genes needed for life to enable clean-chassis engineering
Accessible introductions for newcomers
An accessible introduction to synthetic biology — the field that applies engineering principles to living systems, with applications ranging from biofuels to programmable medicines.
Synthetic biology is redesigning living organisms to solve problems in medicine, agriculture, materials, and manufacturing. Here is what it is, where it is headed, and why it matters.

Craig Venter raced the government to sequence the human genome, then created the first synthetic organism — redefining what it means to engineer life.

Drew Endy pioneered the idea that biology could be engineered like software — creating BioBricks, co-founding iGEM, and championing open-source biology.
Jason Kelly co-founded Ginkgo Bioworks to be the 'organism company' — building the world's largest platform for programming cells and engineering biology at industrial scale.
A standardized DNA part with defined restriction sites, developed at MIT for interchangeable assembly of genetic circuits. The foundation of the iGEM competition and the modular philosophy of synthetic biology.
An automated facility that uses robotics and AI to design, build, and test biological systems at high throughput. Companies like Ginkgo Bioworks operate biofoundries for engineering organisms for industrial applications.
Measures to protect against the misuse of biological research and technology, including engineered pathogens. Increasingly important as gene editing becomes more accessible.
A living cell used as the host platform for synthetic biology engineering. Common chassis include E. coli, yeast, and mammalian cell lines. Minimized chassis like JCVI-syn3.0 are built for predictability.
Adjusting the codon usage of a gene to match the tRNA pool of its host organism, improving protein expression. Essential for recombinant peptide manufacturing and mRNA therapeutic design.
A laboratory technique that mimics natural selection to evolve proteins toward desired functions via iterative mutation and selection. Pioneered by Frances Arnold (Nobel 2018). Enables rapid optimization of enzymes, antibodies, and therapeutics.
An engineered network of genes and regulatory elements designed to perform a specific logical function inside a cell, such as sensing a disease biomarker and producing a therapeutic protein in response.
An engineered assembly of DNA parts (promoters, coding sequences, terminators) designed to perform a specific logical or regulatory function, such as a toggle switch or oscillator.
In synthetic biology, refers to engineered systems that operate independently of and don't interfere with natural cellular machinery. Orthogonal ribosomes, tRNAs, and genetic codes enable precise control without crosstalk.
A DNA sequence upstream of a gene where RNA polymerase and transcription factors bind to initiate transcription. Promoter strength and tissue specificity are central design choices in gene therapy and synthetic biology.
RBS — a short mRNA sequence (Shine-Dalgarno in bacteria, Kozak in eukaryotes) where the ribosome binds to initiate translation. Tunable RBS strength is a standard part in synthetic biology circuit design.
The engineering discipline of designing and building new biological parts, devices, and systems — or redesigning existing natural systems for useful purposes.
A branch of synthetic biology that designs organisms or biomolecules using chemistry not found in nature, such as unnatural nucleotides (XNA), non-canonical amino acids, or expanded genetic codes.